|
1
|
Pathak LA, Shirodkar S, Ruparelia R and
Rajebahadur J: Coronary artery disease in women. Indian Heart J.
69:532–538. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wong ND: Epidemiological studies of CHD
and the evolution of preventive cardiology. Nat Rev Cardiol.
11:276–289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hansson GK: Inflammation, atherosclerosis,
and coronary artery disease. N Engl J Med. 352:1685–1695. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Badimon L and Vilahur G: Thrombosis
formation on atherosclerotic lesions and plaque rupture. J Intern
Med. 276:618–632. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zaman AG, Helft G, Worthley SG and Badimon
JJ: The role of plaque rupture and thrombosis in coronary artery
disease. Atherosclerosis. 149:251–266. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wick G and Grundtman C: Inflammation and
Atherosclerosis. I. Springer-Verlag Wien; Austria: 2011
|
|
7
|
Cervantes Gracia K, Llanas-Cornejo D and
Husi H: CVD and oxidative stress. J Clin Med. 6:222017. View Article : Google Scholar
|
|
8
|
Vogiatzi G, Tousoulis D and Stefanadis C:
The role of oxidative stress in atherosclerosis. Hellenic J
Cardiol. 50:402–409. 2009.PubMed/NCBI
|
|
9
|
Bonomini F, Tengattini S, Fabiano A,
Bianchi R and Rezzani R: Atherosclerosis and oxidative stress.
Histol Histopathol. 23:381–390. 2008.PubMed/NCBI
|
|
10
|
Stocker R and Keaney JF: Role of oxidative
modifications in atherosclerosis. Physiol Rev. 84:1381–1478. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Madamanchi NR, Hakim ZS and Runge MS:
Oxidative stress in atherogenesis and arterial thrombosis: The
disconnect between cellular studies and clinical outcomes. J Thromb
Haemost. 3:254–267. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Valko M, Rhodes CJ, Moncol J, Izakovic M
and Mazur M: Free radicals, metals and antioxidants in oxidative
stress-induced cancer. Chem Biol Interact. 160:1–40. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shao B and Heinecke JW: HDL, lipid
peroxidation, and atherosclerosis. J Lipid Res. 50:599–601. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee SE and Park YS: Role of lipid
peroxidation-derived α, β-unsaturated aldehydes in vascular
dysfunction. Oxid Med Cell Longev. 2013:6290282013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ahmadinejad F, Geir Møller S,
Hashemzadeh-Chaleshtori M, Bidkhori G and Jami M-S: Molecular
Mechanisms behind Free Radical Scavengers Function against
Oxidative Stress. Antioxidants. 6:512017. View Article : Google Scholar
|
|
16
|
Beutler E, Duron O and Kelly BM: Improved
method for the determination of blood glutathione. J Lab Clin Med.
61:882–888. 1963.PubMed/NCBI
|
|
17
|
Kadiiska MB, Gladen BC, Baird DD, Germolec
D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, et
al: Biomarkers of oxidative stress study II: Are oxidation products
of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic
Biol Med. 38:698–710. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Amatuzio DS, Grande F and Wada S: The
cyanmethemoglobin method for hemoglobin determination. Minn Med.
45:378–381. 1962.PubMed/NCBI
|
|
19
|
Cynamon HA, Isenberg JN and Nguyen CH:
Erythrocyte malondialdehyde release in vitro: A functional measure
of vitamin E status. Clin Chim Acta. 151:169–176. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Andersen HR, Nielsen JB, Nielsen F and
Grandjean P: Antioxidative enzyme activities in human erythrocytes.
Clin Chem. 43:562–568. 1997.PubMed/NCBI
|
|
21
|
Sonet J, Bierla K, Bulteau A-L, Lobinski R
and Chavatte L: Comparison of analytical methods using enzymatic
activity, immunoaffinity and selenium-specific mass spectrometric
detection for the quantitation of glutathione peroxidase 1. Anal
Chim Acta. 1011:11–19. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miller NJ, Rice-Evans C, Davies MJ,
Gopinathan V and Milner A: A novel method for measuring antioxidant
capacity and its application to monitoring the antioxidant status
in premature neonates. Clin Sci (Lond). 84:407–412. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Damy T, Kirsch M, Khouzami L, Caramelle P,
Le Corvoisier P, Roudot-Thoraval F, Dubois-Randé JL, Hittinger L,
Pavoine C and Pecker F: Glutathione deficiency in cardiac patients
is related to the functional status and structural cardiac
abnormalities. PLoS One. 4:e48712009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kaur K, Bedi G, Kaur M, Vij A and Kaur I:
Lipid peroxidation and the levels of antioxidant enzymes in
coronary artery disease. Indian J Clin Biochem. 23:33–37. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pamplona R: Membrane phospholipids,
lipoxidative damage and molecular integrity: A causal role in aging
and longevity. Biochim Biophys Acta. 1777:1249–1262. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kumar E, Mukherjee R, Senthil R,
Parasuraman S and Suresh B: Evaluation of oxidative stress and
antioxidant status in patients with cardiovascular disease in rural
populations of the nilgiris, South India. ISRN pharmacol.
2012:9410682012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bhat MA, Mahajan N and Gandhi G: Oxidative
stress status in coronary artery disease patients. Int J Life Sc Bt
Pharm Res. 1:236–243. 2012.
|
|
28
|
Surekha RH, Srikanth BB, Jharna P,
Ramachandra RV, Dayasagar RV and Jyothy A: Oxidative stress and
total antioxidant status in myocardial infarction. Singapore Med J.
48:137–142. 2007.PubMed/NCBI
|
|
29
|
Amaki T, Suzuki T, Nakamura F, Hayashi D,
Imai Y, Morita H, Fukino K, Nojiri T, Kitano S, Hibi N, et al:
Circulating malondialdehyde modified LDL is a biochemical risk
marker for coronary artery disease. Heart. 90:1211–1213. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Serdar Z, Aslan K, Dirican M, Sarandöl E,
Yeşilbursa D and Serdar A: Lipid and protein oxidation and
antioxidant status in patients with angiographically proven
coronary artery disease. Clin Biochem. 39:794–803. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Serdar Z, Yeşilbursa D, Dirican M,
Sarandöl E and Serdar A: Sialic acid and oxidizability of lipid and
proteins and antioxidant status in patients with coronary artery
disease. Cell Biochem Funct. 25:655–664. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vnukov VV, Sidorov RV, Milutina NP,
Ananyan AA, Gvaldin DY, Sagakyants AB, Shlyk IF and Talalaev EP:
Concentration of proinflammatory cytokines, peroxiredoxin-1 and
glutathione peroxidase activity in the blood plasma of patients
with coronary artery disease undergoing coronary artery bypass
grafting. Adv Gerontol. 30:269–275. 2017.(In Russian). PubMed/NCBI
|
|
33
|
Holley AS, Miller JH, Larsen PD and
Harding SA: Relationship between glutathione peroxidase, platelet
reactivity, and reactive oxygen species in an acute coronary
syndrome population. Ann Clin Lab Sci. 46:639–644. 2016.PubMed/NCBI
|
|
34
|
Holley A, Pitman J, Miller J, Harding S
and Larsen P: Glutathione peroxidase activity and expression levels
are significantly increased in acute coronary syndromes. J Investig
Med. 65:919–925. 2017. View Article : Google Scholar : PubMed/NCBI
|
